JP Morgan Maintains Neutral on Zimmer Biomet Holdings, Raises Price Target to $125
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Robbie Marcus maintains a Neutral rating on Zimmer Biomet Holdings (ZBH) and raises the price target from $115 to $125.
February 09, 2024 | 9:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan analyst Robbie Marcus maintains a Neutral rating on Zimmer Biomet Holdings and raises the price target from $115 to $125.
The increase in price target by JP Morgan suggests a positive outlook on the stock's value, potentially leading to short-term price appreciation. However, the Neutral rating indicates that the stock might not outperform the market significantly.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100